Abstract |
The improved efficacy and safety of antiretroviral agents have fundamentally changed the face of HIV infection. Advances in antiretroviral therapy have dramatically improved the prognosis of HIV infection, which is now on a par with other chronic illnesses. This article addresses the optimal timing of antiretroviral therapy initiation and the optimal drug choices for initial regimens, with a focus on recent data and published guidelines issued by the US Department of Health and Human Services and the International AIDS Society-USA.
|
Authors | Jennifer A Johnson, Paul E Sax |
Journal | Current infectious disease reports
(Curr Infect Dis Rep)
Vol. 11
Issue 4
Pg. 311-8
(Jul 2009)
ISSN: 1523-3847 [Print] United States |
PMID | 19545501
(Publication Type: Journal Article)
|